A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 ``PembroRad'' trial.

Xu Shan Sun, Christian Sire, Yungan Tao, Laurent Martin, Marc Alfonsi, et al.. A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 ``PembroRad'' trial.. Journal of Clinical Oncology, American Society of Clinical Oncology, 2018, 36 (15, S), ⟨10.1200/JCO.2018.36.15\_suppl.6018⟩. ⟨hal-03600480⟩